Suppr超能文献

[L-1210白血病及其溶肉瘤素抗性变体的β-肾上腺素能受体特征]

[Characteristics of beta-adrenoreceptors of L-1210 leukemia and its sarcolysine-resistant variant].

作者信息

Khabarov S V

出版信息

Biull Eksp Biol Med. 1987 Jun;103(6):715-7.

PMID:3036273
Abstract

Beta-adrenoceptors have been discovered on the surface of cells of leukaemia L1210 and its variant resistant to sarcolysine (D, L-melphalan). One type of functionally active receptors with dissociation constant Kd for L-[3H] dihydroalprenolol about 0.02 nM and 360 receptors per cell have been revealed in leukaemia L1210 cells. In the resistant cells two types of functionally inactive receptors with Kd1 approximately 0.02 nM (420 receptors per cell) and Kd2 approximately 2.5 nM (3000 receptors per cell) have been revealed. This property of beta-adrenoceptors may be one of the causes of tumour cell resistance to sarcolysine.

摘要

在白血病L1210细胞及其对溶肉瘤素(D,L-美法仑)耐药的变体细胞表面发现了β-肾上腺素能受体。在白血病L1210细胞中发现了一种功能活性受体,其对L-[3H]二氢阿普洛尔的解离常数Kd约为0.02 nM,每个细胞有360个受体。在耐药细胞中发现了两种功能无活性的受体,Kd1约为0.02 nM(每个细胞420个受体),Kd2约为2.5 nM(每个细胞3000个受体)。β-肾上腺素能受体的这一特性可能是肿瘤细胞对溶肉瘤素耐药的原因之一。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验